Stabilized formulations of 6-hydroxy-3-(4-(2-(piperidin-1-yl) ethoxy)phenoxy)-2-(4-methoxyphenyl) benzo(B)thiophene and salts thereof

Details for Australian Patent Application No. 2001255310 (hide)

International Classifications

Event Publications

3 March 2005 Application Accepted

Published as AU-B-2001255310

10 March 2005 Corrigenda

Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2001255310, under INID (54) correct the title to read Stabilized formulations of 6-hydroxy-3-(4-(2-(piperidin-1-yl) ethoxy)phenoxy)-2-(4-methoxyphenyl) benzo(b)thiophene and salts thereof. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002228403 Japan as Represented by President

30 June 2005 Standard Patent Sealed

13 October 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 25 Aug 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

9 March 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Aug 2005 and 26 Sep 2005

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.